Interestingly, mutations in the PI3K alpha catalytic subunit (PI3KCA) is the most common genetic abnormality identified in ER(+) breast cancer (~30%), whereas PTEN loss is more associated with ER(−) disease. The gene discussed is PTEN; the disease is breast cancer.